These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32395414)

  • 1. Inter-laboratory analytical improvement of succinylacetone and nitisinone quantification from dried blood spot samples.
    Laeremans H; Turner C; Andersson T; de Juan JAC; Gerrard A; Heiner-Fokkema MR; Herebian D; Janzen N; la Marca G; Rudebeck M
    JIMD Rep; 2020 May; 53(1):90-102. PubMed ID: 32395414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utilization of dried blood spot nitisinone (NTBC) and succinylacetone (SA) concentrations in hereditary tyrosinaemia type 1 - A UK centre experience.
    Yeo M; Turner C; Dalton NR; Rahman Y; Vara R
    Ann Clin Biochem; 2020 Nov; 57(6):412-419. PubMed ID: 32936663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory monitoring of patients with hereditary tyrosinemia type I.
    Schultz MJ; Netzel BC; Singh RH; Pino GB; Gavrilov DK; Oglesbee D; Raymond KM; Rinaldo P; Tortorelli S; Smith WE; Matern D
    Mol Genet Metab; 2020 Aug; 130(4):247-254. PubMed ID: 32546364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous quantification of succinylacetone and nitisinone for therapeutic drug monitoring in the treatment of Tyrosinemia type 1.
    Sundberg J; Wibrand F; Lund AM; Christensen M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():259-266. PubMed ID: 29195145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots.
    Allard P; Grenier A; Korson MS; Zytkovicz TH
    Clin Biochem; 2004 Nov; 37(11):1010-5. PubMed ID: 15498530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic characteristics of two patients with tyrosinemia type 1 in Slovenia - A novel fumarylacetoacetate hydrolase (
    Sikonja J; Brecelj J; Zerjav Tansek M; Repic Lampret B; Drole Torkar A; Klemencic S; Lipovec N; Stefanova Kralj V; Bertok S; Kovac J; Faganel Kotnik B; Tesarova M; Remec ZI; Debeljak M; Battelino T; Groselj U
    Mol Genet Metab Rep; 2022 Mar; 30():100836. PubMed ID: 35242570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1).
    Das AM
    Appl Clin Genet; 2017; 10():43-48. PubMed ID: 28769581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer.
    Poetto AS; Posocco B; Gagno S; Orleni M; Zanchetta M; Iacuzzi V; Canil G; Buzzo M; Montico M; Guardascione M; Basile D; Pelizzari G; Alberti M; Gerratana L; Puglisi F; Toffoli G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122985. PubMed ID: 34700133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I.
    Magera MJ; Gunawardena ND; Hahn SH; Tortorelli S; Mitchell GA; Goodman SI; Rinaldo P; Matern D
    Mol Genet Metab; 2006 May; 88(1):16-21. PubMed ID: 16448836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-Label Single-Sequence Crossover Study Evaluating Pharmacokinetics, Efficacy, and Safety of Once-Daily Dosing of Nitisinone in Patients with Hereditary Tyrosinemia Type 1.
    Guffon N; Bröijersén A; Palmgren I; Rudebeck M; Olsson B
    JIMD Rep; 2018; 38():81-88. PubMed ID: 28643275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of succinylacetone in dried blood spots and liquid urine as a dansylhydrazone by liquid chromatography tandem mass spectrometry.
    Al-Dirbashi OY; Rashed MS; Brink HJ; Jakobs C; Filimban N; Al-Ahaidib LY; Jacob M; Al-Sayed MM; Al-Hassnan Z; Faqeih E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):274-80. PubMed ID: 16384749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a therapeutic range for nitisinone in patients treated for tyrosinemia type 1 based on reduction of succinylacetone excretion.
    Jack RM; Scott CR
    JIMD Rep; 2019 Mar; 46(1):75-78. PubMed ID: 31240158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and the importance of early treatment of tyrosinemia type 1: A case report.
    Škaričić A; Zekušić M; Fumić K; Rogić D; Uroić V; Petković Ramadža D; Žigman T; Barić I
    Clin Mass Spectrom; 2019 Apr; 12():1-6. PubMed ID: 34841073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved method to determine succinylacetone in dried blood spots for diagnosis of tyrosinemia type 1 using UPLC-MS/MS.
    Al-Dirbashi OY; Rashed MS; Jacob M; Al-Ahaideb LY; Al-Amoudi M; Rahbeeni Z; Al-Sayed MM; Al-Hassnan Z; Al-Owain M; Al-Zeidan H
    Biomed Chromatogr; 2008 Nov; 22(11):1181-5. PubMed ID: 18651606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dried blood spot analysis by digital microfluidics coupled to nanoelectrospray ionization mass spectrometry.
    Shih SC; Yang H; Jebrail MJ; Fobel R; McIntosh N; Al-Dirbashi OY; Chakraborty P; Wheeler AR
    Anal Chem; 2012 Apr; 84(8):3731-8. PubMed ID: 22413743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a fully automated online human dried blood spot analysis of bosentan and its metabolites using the Sample Card And Prep DBS System.
    Ganz N; Singrasa M; Nicolas L; Gutierrez M; Dingemanse J; Döbelin W; Glinski M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 885-886():50-60. PubMed ID: 22227055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC-MS/MS.
    Vu DH; Koster RA; Bolhuis MS; Greijdanus B; Altena RV; Nguyen DH; Brouwers JR; Uges DR; Alffenaar JW
    Talanta; 2014 Apr; 121():9-17. PubMed ID: 24607103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of clozapine and norclozapine in dried plasma spot and dried blood spot by liquid chromatography-tandem mass spectrometry.
    Carniel E; Dos Santos KA; de Andrade de Lima L; Kohlrausch R; Linden R; Antunes MV
    J Pharm Biomed Anal; 2022 Feb; 210():114591. PubMed ID: 35033943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated high-capacity on-line extraction and bioanalysis of dried blood spot samples using liquid chromatography/high-resolution accurate mass spectrometry.
    Oliveira RV; Henion J; Wickremsinhe ER
    Rapid Commun Mass Spectrom; 2014 Nov; 28(22):2415-26. PubMed ID: 25303470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Flow Injection Analysis Method for the Second-Tier Estimation of Succinylacetone in Dried Blood Spot of Newborn Screening.
    Varughese B; Madrewar D; Polipalli SK; Kapoor S
    Indian J Clin Biochem; 2022 Jan; 37(1):40-50. PubMed ID: 35125692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.